SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neurotherapeutics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925001655 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849765467919482880 |
|---|---|
| author | Amy Chappell, M.D. |
| author_facet | Amy Chappell, M.D. |
| author_sort | Amy Chappell, M.D. |
| collection | DOAJ |
| format | Article |
| id | doaj-art-10ff9bf6fbef4751bc42c2c573d54cd4 |
| institution | DOAJ |
| issn | 1878-7479 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Neurotherapeutics |
| spelling | doaj-art-10ff9bf6fbef4751bc42c2c573d54cd42025-08-20T03:04:50ZengElsevierNeurotherapeutics1878-74792025-07-01224e0068710.1016/j.neurot.2025.e00687SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan diseaseAmy Chappell, M.D.0Solaxahttp://www.sciencedirect.com/science/article/pii/S1878747925001655 |
| spellingShingle | Amy Chappell, M.D. SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease Neurotherapeutics |
| title | SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease |
| title_full | SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease |
| title_fullStr | SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease |
| title_full_unstemmed | SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease |
| title_short | SLX-100, a novel immediate release formulation of 4-aminopyridine, for the treatment of Spinocerebellar Ataxia 27B (SCA27B), an orphan disease |
| title_sort | slx 100 a novel immediate release formulation of 4 aminopyridine for the treatment of spinocerebellar ataxia 27b sca27b an orphan disease |
| url | http://www.sciencedirect.com/science/article/pii/S1878747925001655 |
| work_keys_str_mv | AT amychappellmd slx100anovelimmediatereleaseformulationof4aminopyridineforthetreatmentofspinocerebellarataxia27bsca27banorphandisease |